Phase II study of fixed‐duration single‐agent ibrutinib in relapsed nodular lymphocyte‐predominant Hodgkin lymphoma: A report from the German Hodgkin Study Group. Issue 4 (24th March 2022)

Record Type:: Journal Article
Title:: Phase II study of fixed‐duration single‐agent ibrutinib in relapsed nodular lymphocyte‐predominant Hodgkin lymphoma: A report from the German Hodgkin Study Group. Issue 4 (24th March 2022)
Main Title:: Phase II study of fixed‐duration single‐agent ibrutinib in relapsed nodular lymphocyte‐predominant Hodgkin lymphoma: A report from the German Hodgkin Study Group
Authors:: Eichenauer, Dennis A.
Bühnen, Ina
Plütschow, Annette
Kobe, Carsten
Dietlein, Markus
Wendtner, Clemens‐Martin
Thorspecken, Sven
Topp, Max S.
Mauser, Mareike
von Tresckow, Bastian
Fuchs, Michael
Borchmann, Peter
Engert, Andreas
Abstract:
Is Part Of:: Hematological oncology. Volume 40:Issue 4(2022)
Journal:: Hematological oncology
Issue:: Volume 40:Issue 4(2022)
Issue Display:: Volume 40, Issue 4 (2022)
Year:: 2022
Volume:: 40
Issue:: 4
Issue Sort Value:: 2022-0040-0004-0000
Page Start:: 801
Page End:: 804
Publication Date:: 2022-03-24
Subjects:: Btk -- ibrutinib -- NLPHL -- relapse -- salvage therapy
Hematological oncology -- Periodicals
Hematology
Medical Oncology
616.99418005
Journal URLs:: http://onlinelibrary.wiley.com/ ↗
DOI:: 10.1002/hon.2986 ↗
Languages:: English
ISSNs:: 0278-0232
Deposit Type:: Legaldeposit
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:: British Library DSC - 4291.550000
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store
Ingest File:: 24045.xml